Enzo Biochem Launches Proprietary COVID-19 Diagnostic Test Under FDA’s Emergency Use Authorization
Enzo Biochem, Inc. ($0.01 Par Value) (ENZ)
Last enzo biochem, inc. ($0.01 par value) earnings: 12/7 04:10 pm
Check Earnings Report
US:NYSE Investor Relations:
enzo.com/corporate/investor-information
Company Research
Source: Business Wire
First Test Offering Within Enzo’s Comprehensive COVID-19 ProgramProprietary Molecular Diagnostic Kits Offer Improved Scale, Throughput, and Sensitivity NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), a leading biosciences and diagnostic company, today announced its Comprehensive COVID-19 Program incorporating its molecular diagnostic virus screening products, detection for immunity through IgG/IgM serological ELISA products, detection of inflammation on Enzo’s ELISA platform, and a promising proprietary drug candidate (SK1-I). Enzo is utilizing its technological and research and development capabilities, manufacturing infrastructure strength and clinical diagnostic capabilities to provide products that address gaps in performance, cost, supply obtainability and safety. Most diagnostic platforms offered by others are ‘closed’ systems and have no flexibility with regards to adoptability for other infectious agents, have limited supplier relationships, and have no direct con
Show less
Read more
Impact Snapshot
Event Time:
ENZ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ENZ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ENZ alerts
High impacting Enzo Biochem, Inc. ($0.01 Par Value) news events
Weekly update
A roundup of the hottest topics
ENZ
News
- Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- ENZ Stock Falls Post Q1 Earnings Amid Revenue and Demand Challenges [Yahoo! Finance]Yahoo! Finance
- Enzo Biochem First Quarter 2025 Earnings: US$0.059 loss per share (vs US$0.11 loss in 1Q 2024) [Yahoo! Finance]Yahoo! Finance
- Enzo Biochem, Inc. (NYSE: ENZ) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Enzo Biochem Reports First Quarter Fiscal Year 2025 Results and Provides a Company Update [Yahoo! Finance]Yahoo! Finance
ENZ
Sec Filings
- 12/16/24 - Form 10-Q
- 12/2/24 - Form 3
- 11/29/24 - Form ARS
- ENZ's page on the SEC website